AnaptysBio, Inc. (ANAB) has 20 known insider and institutional holders on record. The largest holder is EcoR1 Capital, LLC with 7,860,180 shares. Other notable holders include NODELMAN OLEG and Novo Holdings A/S.
Over the last 12 months, insiders have made 53 transactions in ANAB stock — 10 buys (valued at $140.2K) and 22 sells (valued at $5.13M). Insider selling has exceeded buying during this period.
ANAB Insider Ownership
Top Holder
EcoR1 Capital, LLC
7,860,180 shares
Buys (12 mo)
10
$140.2K value
Sells (12 mo)
22
$5.13M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Ecor1 Capital, Llc |
10 Percent Owner |
7,860,180 |
2025-01-02 |
|
| 2 |
Nodelman Oleg |
Director |
7,521,024 |
2022-05-09 |
|
| 3 |
Novo Holdings A/s |
10 Percent Owner |
1,936,604 |
2017-08-21 |
|
| 4 |
Frazier Healthcare Vii, L.p. |
10 Percent Owner |
973,612 |
2018-05-15 |
|
| 5 |
Frazier Healthcare V, Lp |
10 Percent Owner |
973,612 |
2018-05-15 |
|
| 6 |
Faga Daniel |
President, CEO |
513,644 |
2026-03-27 |
|
| 7 |
Suria Hamza |
President, CEO |
200,000 |
2022-02-14 |
|
| 8 |
Londei Marco |
Chief Medical Officer |
98,000 |
2019-12-10 |
|
| 9 |
Moyle Matthew |
Chief Scientific Officer |
75,000 |
2017-02-28 |
|
| 10 |
Piscitelli Dominic |
Chief Financial Officer |
35,000 |
2019-02-11 |
|
| 11 |
Schmid John P. |
Director |
31,622 |
2026-04-01 |
|
| 12 |
Lizzul Paul F. |
Chief Medical Officer |
25,575 |
2026-01-09 |
|
| 13 |
Mulroy Dennis |
Chief Financial Officer |
20,100 |
2026-01-09 |
|
| 14 |
Loumeau Eric J |
Chief Legal Officer |
12,835 |
2026-02-13 |
|
| 15 |
Schoeneck James A |
Director |
6,000 |
2018-02-06 |
|
| 16 |
Gallagher Carol Giltner |
Director |
6,000 |
2018-02-06 |
|
| 17 |
Orwin John A |
Director |
6,000 |
2026-01-08 |
|
| 18 |
Lydon Nicholas |
Director |
6,000 |
2019-02-11 |
|
| 19 |
Fenton Dennis M |
Director |
4,000 |
2026-01-08 |
|
| 20 |
Jain Rita |
Director |
4,000 |
2026-01-08 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-26 |
Gray Susannah |
Officer |
Unknown |
- |
- |
- |
| 2026-03-30 |
Schmid John P. |
Director |
Informative Sell |
522 |
$57.40 |
$29.96K |
| 2026-03-27 |
Faga Daniel |
President, CEO |
Informative Sell |
100 |
$65.99 |
$6.6K |
| 2026-03-25 |
Faga Daniel |
President, CEO |
RSU Award |
34,300 |
- |
- |
| 2026-02-11 |
Loumeau Eric J |
Chief Legal Officer |
Informative Sell |
10,000 |
$54.00 |
$540K |
| 2026-01-15 |
Marquet Magda |
Director |
Option Exercise (Sell) |
11,000 |
$26.11 |
$287.21K |
| 2026-01-08 |
Lizzul Paul F. |
Chief Medical Officer |
Informative Sell |
3,650 |
$44.71 |
$163.19K |
| 2026-01-07 |
Lizzul Paul F. |
Chief Medical Officer |
Option Exercise (Sell) |
8,525 |
- |
- |
| 2026-01-08 |
Faga Daniel |
President, CEO |
Informative Sell |
14,281 |
$44.71 |
$638.5K |
| 2026-01-07 |
Faga Daniel |
President, CEO |
Option Exercise (Sell) |
26,838 |
- |
- |
| 2026-01-08 |
Mulroy Dennis |
Chief Financial Officer |
Informative Sell |
2,515 |
$44.71 |
$112.45K |
| 2026-01-07 |
Mulroy Dennis |
Chief Financial Officer |
Option Exercise (Sell) |
6,700 |
- |
- |
| 2026-01-08 |
Loumeau Eric J |
Chief Legal Officer |
Informative Sell |
2,210 |
$44.71 |
$98.81K |
| 2026-01-07 |
Loumeau Eric J |
Chief Legal Officer |
Option Exercise |
5,888 |
- |
- |
| 2026-01-06 |
Ware J. Anthony |
Director |
RSU Award |
4,000 |
- |
- |
| 2026-01-07 |
Lizzul Paul F. |
Chief Medical Officer |
Informative Sell |
2,235 |
$45.11 |
$100.82K |
| 2026-01-06 |
Lizzul Paul F. |
Chief Medical Officer |
Option Exercise (Sell) |
6,145 |
- |
- |
| 2026-01-06 |
Jain Rita |
Director |
RSU Award |
4,000 |
- |
- |
| 2026-01-07 |
Faga Daniel |
President, CEO |
Informative Sell |
9,202 |
$45.11 |
$415.1K |
| 2026-01-06 |
Faga Daniel |
President, CEO |
Option Exercise (Sell) |
17,850 |
- |
- |
| 2026-01-06 |
Marquet Magda |
Director |
RSU Award |
4,000 |
- |
- |
| 2026-01-06 |
Schmid John P. |
Director |
RSU Award |
4,000 |
- |
- |
| 2026-01-06 |
Orwin John A |
Director |
RSU Award |
6,000 |
- |
- |
| 2026-01-07 |
Mulroy Dennis |
Chief Financial Officer |
Informative Sell |
1,908 |
$45.11 |
$86.07K |
| 2026-01-06 |
Mulroy Dennis |
Chief Financial Officer |
Option Exercise (Sell) |
5,245 |
- |
- |